View Clinical Trial (Medical Research Study)
Dietary Lutein and the Retinopathy of Prematurity - NCT00672230-97239(Clinical Trial 218835)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Portland |
|
State:
|
|
OR |
| Zip Code: |
|
97239 |
| Conditions: |
|
Lactation |
| Purpose: |
|
The clinical trial aspect of this study is the provision of a lutein supplement to lactating
women and compare the amount of lutein in the milk and blood with lactating women who do not
receive the lutein supplement.
|
| Study summary: |
|
About one-fourth of preterm infants who weight less than 2 3/4 pounds at birth develop an
eye problem. This problem occurs in the retina (back of the eye) and may result in
blindness. This eye problem is called the retinopathy of prematurity(ROP). There are two
yellow pigments in the retina called lutein and zeaxanthin. These pigments may protect the
retina from being damaged by light. They may also protect the retina from being damaged by
oxygen. These pigments are transferred from the mother to the baby. Most of this takes
place during the last trimester of pregnancy. The situation could be worse if the baby
receives formula. Most baby formulas do not contain lutein and zeaxanthin; breast milk
does. Another worry is that breast milk may not have enough lutein and zeaxanthin if the
mother does not eat enough vegetables and fruits. The purpose of this study is to measure
the transfer of lutein and zeaxanthin from the mother to the baby, to measure the amount of
lutein and zeaxanthin in breast milk, to find out if taking a lutein supplement will
increase the amount of lutein in breast milk and to find out if dietary lutein and
zeaxanthin are involved in the development of the retinopathy of prematurity (ROP). |
| Criteria: |
|
Inclusion Criteria:
- Planning to breast feed for at least 12 weeks
- Willing to be randomized to take the lutein supplement
Exclusion Criteria:
- Insufficient quantity of breast milk |
|
|
|
| Study is available at: |
|
Oregon Health and Science University Portland, OR 97239 United States
Primary Contact: Sonja L Connor, MS Email: connors@ohsu.edu Phone: 503-494-7775
Secondary Contact: Sonja L Connor, MS Email: connors@ohsu.edu Phone: 503-494-7775 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|